Skip to content

The efficacy and safety of heattherapy and coldtherapy in the treatment of wart

The efficacy and safety of thermotherapy and cryotherapy in the treatment of wart

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015010120514N1
Enrollment
60
Registered
2015-01-25
Start date
2015-02-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wart. B07

Interventions

Intervention 1: Intervention group : Thermotherapy once. Intervention 2: Control group: Cryotherapy every two weeks until warts are removed or for maximum six sessions.
Treatment - Other
Treatment - Drugs
Intervention group : Thermotherapy once
Control group: Cryotherapy every two weeks until warts are removed or for maximum six sessions.

Sponsors

Vice Chancellor for Reasearch of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of 18 years old and above; less than 10 warts; signed informed consent voluntarily and knowingly. Exclusion criteria: being treated during the last two months; warts on the face and genital; plane warts; pregnancy; breast feeding; intolerance to heat; intolerance to cold; diabetes mellitus; peripheral vascular disease; immunodeficiency.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Disappearing of wart. Timepoint: Before the intervention, every month in thermotherapy group after discontinuation of tretment for three month and in cryotherapy group before the intervention and every two weeks for the maximum six sessions and then 3 months after the discontinuation of treatment. Method of measurement: physical examination, Digital photography, patient's satisfaction.

Secondary

MeasureTime frame
Blister. Timepoint: After each session of intervention. Method of measurement: Asking patients.;Ulcer. Timepoint: After each session of intervention. Method of measurement: Asking patients.;Infection. Timepoint: After each session of intervention. Method of measurement: Asking patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Leila Izadi Firouzabadi

Tehran University of Medical Science

lilaizadi@yahoo.com+98 21 5566 4089

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026